1. Home
  2. ELME vs MNKD Comparison

ELME vs MNKD Comparison

Compare ELME & MNKD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ELME
  • MNKD
  • Stock Information
  • Founded
  • ELME 1960
  • MNKD 1991
  • Country
  • ELME United States
  • MNKD United States
  • Employees
  • ELME N/A
  • MNKD N/A
  • Industry
  • ELME Real Estate Investment Trusts
  • MNKD Biotechnology: Pharmaceutical Preparations
  • Sector
  • ELME Real Estate
  • MNKD Health Care
  • Exchange
  • ELME Nasdaq
  • MNKD Nasdaq
  • Market Cap
  • ELME 1.4B
  • MNKD 1.2B
  • IPO Year
  • ELME N/A
  • MNKD 2004
  • Fundamental
  • Price
  • ELME $17.13
  • MNKD $5.57
  • Analyst Decision
  • ELME Hold
  • MNKD Strong Buy
  • Analyst Count
  • ELME 7
  • MNKD 5
  • Target Price
  • ELME $15.50
  • MNKD $10.80
  • AVG Volume (30 Days)
  • ELME 924.7K
  • MNKD 5.6M
  • Earning Date
  • ELME 11-03-2025
  • MNKD 11-06-2025
  • Dividend Yield
  • ELME 4.22%
  • MNKD N/A
  • EPS Growth
  • ELME N/A
  • MNKD 149.32
  • EPS
  • ELME N/A
  • MNKD 0.11
  • Revenue
  • ELME $245,911,000.00
  • MNKD $301,736,000.00
  • Revenue This Year
  • ELME N/A
  • MNKD $14.52
  • Revenue Next Year
  • ELME $6.20
  • MNKD $12.81
  • P/E Ratio
  • ELME N/A
  • MNKD $51.57
  • Revenue Growth
  • ELME 4.59
  • MNKD 21.48
  • 52 Week Low
  • ELME $13.95
  • MNKD $3.38
  • 52 Week High
  • ELME $18.49
  • MNKD $7.63
  • Technical
  • Relative Strength Index (RSI)
  • ELME 61.44
  • MNKD 69.11
  • Support Level
  • ELME $16.84
  • MNKD $5.36
  • Resistance Level
  • ELME $17.25
  • MNKD $5.68
  • Average True Range (ATR)
  • ELME 0.18
  • MNKD 0.30
  • MACD
  • ELME -0.02
  • MNKD 0.07
  • Stochastic Oscillator
  • ELME 69.05
  • MNKD 74.18

About ELME Elme Communities

Elme Communities is a real estate investment trust engaged in owning and operating properties in the greater Washington DC metropolitan area. The company's real estate portfolio is comprised of office, retail, and multifamily properties located near transportation nodes. Washington REIT derives nearly all of its income in the form of rental revenue from tenants organized into long-term leases. The company's office assets contribute the majority of this income, while the rest is split fairly evenly between its retail and multifamily locations. Washington REIT's tenants are banking, consulting, law, and financial services firms.

About MNKD MannKind Corporation

MannKind Corp is a biopharmaceutical company focused on the development and commercialization of inhaled therapeutic products for patients with diseases such as diabetes and pulmonary arterial hypertension. Its approved product, Afrezza (insulin human) Inhalation Powder, is an ultra-rapid-acting inhaled insulin used to improve glycemic control in adults with diabetes. The product consists of a dry powder formulation of human insulin delivered from a small portable inhaler.

Share on Social Networks: